Pesticides and oncogenic modulation

Elena Vakonaki1, Vasilis P Androutsopoulos, Jyrki Liesivuori

  • 1Laboratory of Toxicology, University of Crete, Medical School, Crete 71409, Greece.

Toxicology
|January 29, 2013
PubMed

Insights

Pesticide exposure, including organochlorine and organophosphate types, may lead to cell mutations and cancer. Research links pesticide use to oncogene and tumor suppressor gene damage in lab studies and human populations.

Area of Science:

  • Environmental toxicology
  • Molecular oncology

Background:

  • Pesticides are widely used in agriculture.
  • Organochlorine and organophosphate pesticides are linked to malignant cell transformation.

Purpose of the Study:

  • To summarize recent in vitro and human population findings on pesticide exposure's impact on oncogenes and tumor suppressor genes.
  • To explore the mechanisms of pesticide-induced cancer development.

Main Methods:

  • Review of in vitro studies on cell transformation.
  • Analysis of human population studies on pesticide exposure and cancer-related gene mutations.

Main Results:

  • In vitro studies show pesticides can induce oncogene mutations and increase transcriptional expression.
  • Human population studies suggest associations between pesticide exposure and mutations in cancer-related genes.

Conclusions:

  • Pesticide exposure may disrupt the normal function of oncogenes and tumor suppressor genes.
  • Further research is needed to elucidate the precise mechanisms in human populations.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...